- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Skin fissures.
Displaying page 1 of 1.
EudraCT Number: 2006-003369-14 | Sponsor Protocol Number: V00034 CR 309 1B | Start Date*: 2006-12-12 | |||||||||||
Sponsor Name:PIERRE FABRE MEDICAMENT | |||||||||||||
Full Title: Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel g... | |||||||||||||
Medical condition: Patients presenting with ichthyosis | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) EE (Completed) CZ (Completed) NL (Completed) DE (Completed) LT (Completed) FR (Completed) LV (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004606-24 | Sponsor Protocol Number: 04.168-11 | Start Date*: 2005-01-24 |
Sponsor Name:Fujisawa GmbH | ||
Full Title: A randomized, open-label, monocentric clinical phase I/IV study in healthy human volunteers to evaluate the skin tolerability and cosmetic acceptance of three marketed anti-acne drugs (Differin® Cr... | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003272-12 | Sponsor Protocol Number: 18-ICH-001 | Start Date*: 2019-10-14 | |||||||||||
Sponsor Name:Mayne Pharma LLC | |||||||||||||
Full Title: A Phase 2 Randomized, Multi-center, Double-blind, Vehicle-controlled, 12-Week, Safety, Efficacy, and Systemic Exposure Study followed by a 12-Week Open-label Extension of Trifarotene (CD5789) Cream... | |||||||||||||
Medical condition: Lamellar ichthyosis (LI) Autosomal Recessive Ichthyosis with Lamellar Scale | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001561-32 | Sponsor Protocol Number: 201900237 | Start Date*: 2020-04-28 | ||||||||||||||||
Sponsor Name:University Medical Center Groningen | ||||||||||||||||||
Full Title: Dupilumab in adults with severe chronic hand eczema with an inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled proof of concept efficacy study | ||||||||||||||||||
Medical condition: Hand eczema | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000758-81 | Sponsor Protocol Number: Chlorhex-KKDS-2021 | Start Date*: 2021-04-08 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Chlorhexidine gluconate as treatment and prophylaxis of vulvovaginal Candidiasis | ||
Medical condition: Candida vulvovaginitis | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003488-12 | Sponsor Protocol Number: 54659 | Start Date*: 2016-08-23 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospective open-label trial with blinded outcome assessment. | ||
Medical condition: Hand eczema (HE) is a common condition with a 1-year period prevalence up to 10%. Systemic treatment with alitretinoin is registered for all clinical types of HE. However, it is especially effectiv... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022439-12 | Sponsor Protocol Number: ATH008-CLN02 | Start Date*: 2011-02-03 | |||||||||||
Sponsor Name:Advancell Advanced In Vitro Cell Technologies, S.A | |||||||||||||
Full Title: A Phase II Placebo Controlled, Multicenter Study to Investigate the Safety and Efficacy of ATH008 cream in Patients with Palmar-Plantar Erythrodysesthesia Syndrome (PPES) secondary to capecitabine ... | |||||||||||||
Medical condition: Palmar-Plantar Erythrodysesthesia Syndrome (PPES) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) ES (Ongoing) DE (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
